UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis

Clinical cancer research, 2020-08, Vol.26 (16), p.4280-4288

2020

Volltextzugriff (PDF)

FDA Approval: Blinatumomab

Clinical cancer research, 2015-09, Vol.21 (18), p.4035-4039

2015

Volltextzugriff (PDF)

FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease

The oncologist (Dayton, Ohio), 2020-02, Vol.25 (2), p.e328-e334

2020

Volltextzugriff (PDF)

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Clinical cancer research, 2013-09, Vol.19 (17), p.4559-4563

2013

Volltextzugriff (PDF)

Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses

Journal of clinical oncology, 2022-03, Vol.40 (8), p.847-854

2022

Volltextzugriff (PDF)

FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults

Clinical cancer research, 2020-01, Vol.26 (2), p.328-331

2020

Volltextzugriff (PDF)

Considerations in the development of circulating tumor cell technology for clinical use

Journal of translational medicine, 2012-07, Vol.10 (1), p.138-138, Article 138

2012

Volltextzugriff (PDF)

Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis

Leukemia, 2020-11, Vol.34 (11), p.3082-3084

2020

Volltextzugriff (PDF)

Damage associated molecular pattern molecules

Clinical immunology (Orlando, Fla.), 2007-07, Vol.124 (1), p.1-4

2007

Volltextzugriff (PDF)

Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2078-2085

2007

Volltextzugriff (PDF)

Recent Advances and Current Challenges in Tumor Immunology and Immunotherapy

Molecular therapy, 2007-06, Vol.15 (6), p.1065-1071

2007

Volltextzugriff (PDF)

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

Journal of Virology, 2004-01, Vol.78 (1), p.116-123

2004

Volltextzugriff (PDF)

FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease

Clinical cancer research, 2019-01, Vol.25 (2), p.473-477

2019

Volltextzugriff (PDF)

STAT3-Mediated Signaling in the Determination of Rod Photoreceptor Cell Fate in Mouse Retina

Investigative ophthalmology & visual science, 2004-07, Vol.45 (7), p.2407-2412

2004

Volltextzugriff (PDF)

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Clinical cancer research, 2019-06, Vol.25 (11), p.3205-3209

2019

Volltextzugriff (PDF)

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

Molecular and Cellular Biology, 1995-06, Vol.15 (6), p.3032-3040

1995

Volltextzugriff (PDF)

Vector Targeting Makes 5-Fluorouracil Chemotherapy Less Toxic and More Effective in Animal Models of Epithelial Neoplasms

Clinical cancer research, 2004-11, Vol.10 (22), p.7738-7746

2004

Volltextzugriff (PDF)

Methods for delivery of adenoviral vectors to tumor vasculature

Human gene therapy, 2007-02, Vol.18 (2), p.151-160

2007

Volltextzugriff (PDF)

Genetic Systems for the Diagnosis and Treatment of Human Disease

Cancer biology & therapy, 2004-01, Vol.3 (1), p.126-131

Deisseroth, Albert

2004

Volltextzugriff (PDF)

Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon

Cancer gene therapy, 2003-05, Vol.10 (5), p.388-395

2003

Volltextzugriff (PDF)

FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease

Clinical cancer research, 2015-03, Vol.21 (5), p.950-954

2015

Volltextzugriff (PDF)

Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells

Human pathology, 2007-07, Vol.38 (7), p.1047-1056

2007

Volltextzugriff (PDF)

Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer

Molecular cancer therapeutics, 2006-08, Vol.5 (8), p.1975-1985

2006

Volltextzugriff (PDF)

Acute Myeloid Leukemia Response Measures Other Than Complete Remission

Journal of clinical oncology, 2015-11, Vol.33 (31), p.3675-3676

2015

Volltextzugriff (PDF)

Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G‐CSF in Breast Cancer Patients

Clinical pharmacology and therapeutics, 2018-10, Vol.104 (4), p.742-748

2018

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(169)

Publikationsform

Artikel
(189)

Sprache

Englisch
(189)

Erscheinungsjahr

n.n

Thema

Science & Technology
(189)
Humans
(160)
Oncology
(79)
Biological And Medical Sciences
(78)
Female
(66)
Medical Sciences
(64)
Hematology
(59)
Adult
(51)
Middle Aged
(49)
Male
(46)
Animals
(42)
Base Sequence
(27)
Hematologic And Hematopoietic Diseases
(26)
Molecular Sequence Data
(25)
Aged
(24)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Bone Marrow Transplantation
(22)
Mice
(21)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis

FDA Approval: Blinatumomab

FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses

FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults

Considerations in the development of circulating tumor cell technology for clinical use

Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis

Damage associated molecular pattern molecules

Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma

Recent Advances and Current Challenges in Tumor Immunology and Immunotherapy

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease

STAT3-Mediated Signaling in the Determination of Rod Photoreceptor Cell Fate in Mouse Retina

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

Vector Targeting Makes 5-Fluorouracil Chemotherapy Less Toxic and More Effective in Animal Models of Epithelial Neoplasms

Methods for delivery of adenoviral vectors to tumor vasculature

Genetic Systems for the Diagnosis and Treatment of Human Disease

Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon

FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease

Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells

Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer

Acute Myeloid Leukemia Response Measures Other Than Complete Remission

Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G‐CSF in Breast Cancer Patients

Aktive Filter

Suchergebnisse filtern